PubRank

A Kharazmi

Author PubWeight™ 144.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 1999 3.03
2 Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect 2001 2.50
3 Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm. Antimicrob Agents Chemother 1991 2.09
4 Antileishmanial chalcones: statistical design, synthesis, and three-dimensional quantitative structure-activity relationship analysis. J Med Chem 1998 2.06
5 Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms. Infect Immun 1990 1.81
6 The antileishmanial activity of novel oxygenated chalcones and their mechanism of action. J Antimicrob Chemother 1999 1.77
7 Immunological features of kala-azar. Am J Trop Med Hyg 1978 1.61
8 Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect Immun 1990 1.51
9 Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect Immun 1993 1.50
10 Evaluation of the efficacy of Iran leishmanin and comparison with leishmanins from Wellcome (UK) and Roma (Italy) in cured cutaneous leishmaniasis patients. Trans R Soc Trop Med Hyg 1994 1.45
11 Random amplified polymorphic DNA for the differentiation of Leishmania donovani isolates from Sudan. Trans R Soc Trop Med Hyg 1996 1.41
12 High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clin Exp Immunol 1998 1.40
13 Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection. Infect Immun 2000 1.39
14 Pseudomonas aeruginosa exoproteases inhibit human neutrophil chemiluminescence. Infect Immun 1984 1.37
15 Effect of cyclosporin A on human neutrophil and monocyte function. Scand J Immunol 1985 1.35
16 Interaction of Pseudomonas aeruginosa alkaline protease and elastase with human polymorphonuclear leukocytes in vitro. Infect Immun 1984 1.34
17 The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS 2000 1.33
18 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 1992 1.29
19 Structure-activity studies: in vitro antileishmanial and antimalarial activities of anthraquinones from Morinda lucida. Planta Med 1999 1.24
20 Blood monocyte and neutrophil functions in the acquired immune deficiency syndrome. Scand J Immunol 1986 1.22
21 Virulence factors of Pseudomonas aeruginosa. Antibiot Chemother (1971) 1987 1.21
22 The novel oxygenated chalcone, 2,4-dimethoxy-4'-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites Plasmodium berghei and Plasmodium yoelii in vivo. J Infect Dis 1997 1.18
23 Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones. Antimicrob Agents Chemother 2001 1.17
24 Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 2009 1.17
25 Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrob Agents Chemother 1994 1.16
26 Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Clin Exp Immunol 1994 1.16
27 Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania. Antimicrob Agents Chemother 1993 1.14
28 Suppression of parasite-specific response in Plasmodium falciparum malaria. A longitudinal study of blood mononuclear cell proliferation and subset composition. Scand J Immunol 1986 1.14
29 Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T-helper cell response. APMIS 1999 1.12
30 The use of a water-soluble formazan complex to quantitate the cell number and mitochondrial function of Leishmania major promastigotes. Parasitol Res 1994 1.12
31 The polymerase chain reaction can reveal the occurrence of naturally mixed infections with Leishmania parasites. Acta Trop 1994 1.11
32 Interferon-gamma- and tumour necrosis factor-alpha-producing cells in humans who are immune to cutaneous leishmaniasis. Scand J Immunol 1999 1.11
33 Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani. Antimicrob Agents Chemother 1994 1.11
34 Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile. J Pathol 1999 1.10
35 The contrasting roles of CD4+ T cells in intracellular infections in humans: leishmaniasis as an example. Immunol Today 1996 1.10
36 The antileishmanial agent licochalcone A interferes with the function of parasite mitochondria. Antimicrob Agents Chemother 1995 1.10
37 Leishmania resistant to sodium stibogluconate: drug-associated macrophage-dependent killing. Parasitol Res 1994 1.09
38 Enhanced inhibition of in vitro multiplication of Plasmodium falciparum by stimulated human polymorphonuclear leucocytes. Clin Exp Immunol 1984 1.09
39 Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response. Clin Exp Immunol 2002 1.08
40 Evaluation of the polymerase chain reaction in the diagnosis of cutaneous leishmaniasis due to Leishmania major: a comparison with direct microscopy of smears and sections from lesions. Trans R Soc Trop Med Hyg 1996 1.07
41 Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease. Clin Exp Immunol 1986 1.07
42 Inhibition of human natural killer cell activity by Pseudomonas aeruginosa alkaline protease and elastase. Infect Immun 1987 1.07
43 Polymorphonuclear leucocytes defective in oxidative metabolism inhibit in vitro growth of Plasmodium falciparum. Evidence against an oxygen-dependent mechanism. Scand J Immunol 1984 1.07
44 Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major. Clin Immunol 1999 1.03
45 Diagnosis of visceral leishmaniasis by the polymerase chain reaction using blood, bone marrow and lymph node samples from patients from the Sudan. Trop Med Int Health 1997 1.02
46 Proliferation induced by Plasmodium falciparum antigen and interleukin-2 production by lymphocytes isolated from malaria-immune individuals. Infect Immun 1986 1.02
47 Activation of human T lymphocytes by Leishmania lipophosphoglycan. Scand J Immunol 1991 1.01
48 Rose hip herbal remedy in patients with rheumatoid arthritis - a randomised controlled trial. Phytomedicine 2009 1.01
49 Pretreatment with granulocyte colony-stimulating factor attenuates the inflammatory response but not the bacterial load in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits. Infect Immun 1999 1.00
50 Characterization of the respiratory chain of Helicobacter pylori. FEMS Immunol Med Microbiol 1999 1.00
51 Cellular and humoral immune responses in a population from the Baringo District, Kenya to Leishmania promastigote lipophosphoglycan. Am J Trop Med Hyg 1992 1.00
52 Some bacterial parameters influencing the neutrophil oxidative burst response to Pseudomonas aeruginosa biofilms. APMIS 1992 1.00
53 Detection and characterization of Leishmania in tissues of patients with post kala-azar dermal leishmaniasis using a specific monoclonal antibody. Trans R Soc Trop Med Hyg 1997 1.00
54 Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis. Clin Exp Immunol 1999 1.00
55 The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC). Clin Exp Immunol 2000 0.99
56 Cell-mediated immunity to Plasmodium falciparum infection: evidence against the involvement of cytotoxic lymphocytes. Scand J Immunol 1988 0.99
57 Leishmanicidal, antiplasmodial, and cytotoxic activity of novel diterpenoid 1,2-quinones from Perovskia abrotanoides: new source of tanshinones. J Nat Prod 2001 0.99
58 Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats. Antimicrob Agents Chemother 1997 0.98
59 Complement activation by Pseudomonas aeruginosa biofilms. Microb Pathog 1993 0.98
60 Antiprotozoal compounds from Asparagus africanus. J Nat Prod 1997 0.98
61 Leishmania major surface protease Gp63 interferes with the function of human monocytes and neutrophils in vitro. APMIS 1994 0.97
62 Serodiagnosis of Leishmania donovani infections: assessment of enzyme-linked immunosorbent assays using recombinant L. donovani gene B protein (GBP) and a peptide sequence of L. donovani GBP. Trans R Soc Trop Med Hyg 1999 0.96
63 A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with osteoarthritis--a double-blind, placebo-controlled, randomised trial. Phytomedicine 2004 0.95
64 Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases. Infect Immun 1988 0.94
65 Humoral and cellular immune responses to synthetic peptides of the Leishmania donovani kinetoplastid membrane protein-11. Scand J Immunol 1998 0.94
66 Priming of neutrophils for enhanced oxidative burst by sputum from cystic fibrosis patients with Pseudomonas aeruginosa infection. Eur J Clin Invest 1987 0.94
67 Interferon-gamma production by human T cells and natural killer cells in vitro in response to antigens from the two intracellular pathogens Mycobacterium tuberculosis and Leishmania major. Scand J Immunol 1997 0.93
68 Eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Detection by enzyme-linked immunosorbent assay and purification from normal human urine. J Immunol Methods 1991 0.92
69 Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Th1 activity is associated with severe infections. Clin Exp Immunol 1995 0.92
70 Demonstration of neutrophil chemotactic activity in the sputum of cystic fibrosis patients with Pseudomonas aeruginosa infection. Eur J Clin Invest 1986 0.91
71 Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia. Clin Diagn Lab Immunol 1998 0.91
72 Field application of an ELISA using redefined Leishmania antigens for the detection of visceral leishmaniasis. Trans R Soc Trop Med Hyg 1993 0.90
73 Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia. J Cyst Fibros 2006 0.90
74 Generation of reactive oxygen radicals by human phagocytic cells activated by Plasmodium falciparum. Scand J Immunol 1987 0.89
75 Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay. J Immunol Methods 1991 0.89
76 Interleukin-4 and interferon-gamma production by Leishmania stimulated peripheral blood mononuclear cells from nonexposed individuals. Scand J Immunol 1995 0.89
77 Influence of in vivo hypobaric hypoxia on function of lymphocytes, neutrocytes, natural killer cells, and cytokines. J Appl Physiol (1985) 1993 0.89
78 Functional and phenotypic changes in human lymphocytes after coincubation with Leishmania donovani in vitro. Infect Immun 1990 0.89
79 The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major. FEMS Immunol Med Microbiol 1998 0.88
80 The anti-inflammatory properties of rose-hip. Inflammopharmacology 1999 0.88
81 The pathology of cutaneous leishmaniasis due to Leishmania major in Sudan. Am J Trop Med Hyg 1995 0.88
82 Measurement of serum antibodies against native Leishmania gp63 distinguishes between ongoing and previous L. donovani infection. APMIS 1993 0.88
83 Oronasal leishmaniasis caused by a parasite with an unusual isoenzyme profile. Am J Trop Med Hyg 1997 0.87
84 Effects of Radix Angelicae sinensis and shuanghuanglian on a rat model of chronic Pseudomonas aeruginosa pneumonia. Chin Med Sci J 2000 0.87
85 Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally. Clin Exp Immunol 2000 0.87
86 Effect of Pseudomonas aeruginosa proteases on human leukocyte phagocytosis and bactericidal activity. Acta Pathol Microbiol Immunol Scand C 1986 0.87
87 Alpha heavy-chain disease in southern Iran. Am J Dig Dis 1977 0.86
88 Low parasite specific T cell response in clinically immune individuals with low grade Plasmodium falciparum parasitaemia. Trans R Soc Trop Med Hyg 1986 0.86
89 Molecular characterization of a Leishmania donovanii cDNA clone with similarity to human 20S proteasome a-type subunit. Biochim Biophys Acta 2000 0.86
90 Alpha-chain disease and its association with intestinal lymphoma. Clin Exp Immunol 1976 0.86
91 Induction of oxygen free radical generation in human monocytes by lipoprotein(a). Eur J Clin Invest 1994 0.86
92 Inhibition of human lymphocyte proliferative response by serum from Plasmodium falciparum infected patients. Acta Pathol Microbiol Immunol Scand C 1987 0.86
93 The major surface glycoprotein (gp63) from Leishmania major and Leishmania donovani cleaves CD4 molecules on human T cells. J Immunol 1994 0.86
94 Diversity among Leishmania isolates from the Sudan: isoenzyme homogeneity of L. donovani versus heterogeneity of L. major. Trans R Soc Trop Med Hyg 1995 0.85
95 Interferon-gamma and interleukin-4 in human Leishmania donovani infections. Immunol Cell Biol 1993 0.85
96 Leishmania interaction with human monocytes and neutrophils: modulation of the chemotactic response. APMIS 1989 0.85
97 Neutrophil response, serum opsonic activity, and precipitating antibodies in human infection with Actinobacillus hominis. APMIS 1988 0.85
98 Effects of Legionella pneumophila sonicate on human neutrophil granulocyte and monocyte chemotaxis. Eur J Clin Invest 1986 0.84
99 Tetranectin: a novel secretory protein from human monocytes. Scand J Immunol 1993 0.84
100 Evidence for the presence of circulating immune complexes in serum and C3b and C3d on red cells of kala-azar patients. Trans R Soc Trop Med Hyg 1982 0.83
101 Selective modulation of the CD4 molecular complex by Pseudomonas aeruginosa alkaline protease and elastase. Scand J Immunol 1987 0.83
102 Effect of Legionella pneumophila cytotoxic protease on human neutrophil and monocyte function. Microb Pathog 1992 0.83
103 Indomethacin in vitro and in vivo abolishes post-exercise suppression of natural killer cell activity in peripheral blood. Int J Sports Med 1990 0.83
104 Effect of antimalarial drugs on human neutrophil chemotaxis in vitro. Acta Pathol Microbiol Immunol Scand C 1983 0.83
105 Modifications of the alpha,beta-double bond in chalcones only marginally affect the antiprotozoal activities. Bioorg Med Chem 1998 0.83
106 Effect of oral N-acetylcysteine administration on human blood neutrophil and monocyte function. APMIS 1988 0.83
107 Tumor necrosis factor-alpha increases myocardial microvascular transport in vivo. Am J Physiol 1994 0.82
108 Leishmanicidal, antiplasmodial and cytotoxic activity of indole alkaloids from Corynanthe pachyceras. Planta Med 2000 0.82
109 Production of interferon-gamma and interleukin-4 by human T cells recognizing Leishmania lipophosphoglycan-associated protein. Immunol Lett 1993 0.82
110 Faster activation of polymorphonuclear neutrophils in resistant mice during early innate response to Pseudomonas aeruginosa lung infection. Clin Exp Immunol 2004 0.82
111 Measurement of eosinophil cationic protein (ECP) and eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Time and temperature dependent spontaneous release in vitro demands standardized sample processing. J Immunol Methods 1993 0.82
112 Phagocytosis and bactericidal activity of human leucocytes under influence of antimalarial drugs. Trans R Soc Trop Med Hyg 1986 0.82
113 Serodiagnosis of cutaneous leishmaniasis: assessment of an enzyme-linked immunosorbent assay using a peptide sequence from gene B protein. Am J Trop Med Hyg 1996 0.82
114 Eosinophil cationic protein in sputum from cystic fibrosis patients with Pseudomonas aeruginosa infections. Lancet 1994 0.81
115 Extracellular lipase of Pseudomonas aeruginosa: biochemical characterization and effect on human neutrophil and monocyte function in vitro. Microb Pathog 1991 0.81
116 Interferon-gamma and interleukin-4 production by human T cells recognizing Leishmania donovani antigens separated by SDS-PAGE. APMIS 1995 0.81
117 Antiprotozoal properties of 16,17-dihydrobrachycalyxolide from Vernonia brachycalyx. Planta Med 1998 0.81
118 Primary upper small-intestinal lymphoma and alpha-chain disease. Report of 10 cases emphasizing pathological aspects. Am J Surg Pathol 1978 0.81
119 Comparison of adherent and non-adherent staphylococci in the induction of polymorphonuclear leukocyte activation in vitro. APMIS 1995 0.81
120 Two new antiprotozoal 5-methylcoumarins from Vernonia brachycalyx. J Nat Prod 1997 0.80
121 Pseudomonas aeruginosa exotoxin A primes human monocyte oxidative burst response in vitro. Microb Pathog 1989 0.80
122 N-acetylcysteine attenuates oxidative burst by neutrophils in response to ergometer rowing with no effect on pulmonary gas exchange. Int J Sports Med 2001 0.79
123 Neutrophil chemotactic activity in bronchoalveolar lavage fluid of patients with AIDS-associated Pneumocystis carinii pneumonia. Scand J Infect Dis 1997 0.79
124 Modulation of the counts and functions of neutrophils and monocytes under in vivo hyperthermia conditions. Int J Hyperthermia 1994 0.78
125 Effect of streptokinase on human neutrophil function in vitro and in patients with acute myocardial infarction. J Mol Cell Cardiol 1994 0.78
126 Immunoperoxidase study in alpha-chain disease. Arch Pathol Lab Med 1978 0.78
127 Suppression of blood monocyte and neutrophil chemotaxis in acute human malaria. Parasite Immunol 1986 0.78
128 Dichotomy in the human CD4+ T-cell response to Leishmania parasites. APMIS 1994 0.78
129 Immunology of Pseudomonas aeruginosa infection in cystic fibrosis. Acta Univ Carol Med (Praha) 1990 0.78
130 In vitro Leishmania major promastigote-induced macrophage migration is modulated by sensory and autonomic neuropeptides. Scand J Immunol 1998 0.78
131 Induction of oxidative burst response in human neutrophils by adherent staphylococci. Comparison between Staphylococcus epidermidis and Staphylococcus aureus. APMIS 1993 0.78
132 Alginate in infection. Antibiot Chemother (1971) 1991 0.78
133 Neutrophil chemotactic activity of peptidoglycan. A comparison between Staphylococcus aureus and Staphylococcus epidermidis. APMIS 1990 0.77
134 Modulation of human neutrophil and monocyte oxidative burst by Legionella pneumophila sonic extract. Eur J Clin Microbiol 1987 0.77
135 Enhancement of human natural cytotoxicity by Plasmodium falciparum antigen activated lymphocytes. Acta Trop 1987 0.77
136 Indirect assessment of eosinophiluria in urinary schistosomiasis using eosinophil cationic protein (ECP) and eosinophil protein X (EPX). Acta Trop 1993 0.77
137 Down-regulation of natural killer cell activity by autologous polymorphonuclear leucocytes. Role of indomethacin. Allergy 1988 0.76
138 Th1-like human T-cell clones recognizing Leishmania gp63 inhibit Leishmania major in human macrophages. Scand J Immunol 1994 0.76
139 An antileishmanial chalcone from Chinese licorice roots. Planta Med 1994 0.76
140 Computer-assisted image analysis assay of human neutrophil chemotaxis in vitro. J Immunol Methods 1991 0.76
141 Antimalarial drugs and human neutrophil oxidative metabolism. Trans R Soc Trop Med Hyg 1986 0.76
142 In vitro effects of artesunate and other antimalarial agents on the function of human lymphocytes and neutrophils. Transplant Proc 1994 0.75
143 T and B lymphocytes in alpha-chain disease. Br J Cancer 1978 0.75
144 Absolute configuration and antiprotozoal activity of minquartynoic acid. J Nat Prod 2000 0.75
145 Killing of ofloxacin-exposed pneumococci by human neutrophils. J Antimicrob Chemother 1992 0.75
146 Opsonic activity of serum in the acute phase of meningitis. Acta Pathol Microbiol Immunol Scand C 1986 0.75
147 Binding of E. coli to human blood leukocytes. APMIS 1988 0.75
148 Induction of oxidative burst response in human neutrophils by immune complexes made in vitro of lipopolysaccharide and hyperimmune serum from chronically infected patients. APMIS 1993 0.75
149 Thioxanthenes inhibit multiplication of Leishmania major and its attachment to human monocytes in vitro. Acta Trop 1993 0.75
150 A description of parasite-harbouring cells in localized lymphadenitis in dry type cutaneous leishmaniasis. Acta Trop 2001 0.75
151 In vitro effect of fansimef on human neutrophil and monocyte function. Eur J Clin Pharmacol 1986 0.75
152 Structural and optical properties of erbium-doped willemite-based glass-ceramics. Appl Opt 2015 0.75
153 The role of N-acetylcystein administration on the oxidative response of neutrophils during cardiopulmonary bypass. Perfusion 1995 0.75
154 Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1992 0.75
155 Immunological properties of meningococcal lipopolysaccharide from serogroups A, B & C. APMIS 1996 0.75
156 Survival and function of phagocytes in blood culture media. APMIS 1999 0.75
157 Gitadyl versus ibuprofen in patients with osteoarthritis: a double-blind, randomized, cross-over study of clinical efficacy and effects on platelets and PMNs. Inflammopharmacology 1998 0.75
158 Phagocyte function after splenic autotransplantation. Arch Surg 1990 0.75
159 In vitro modulation of human neutrophil chemotaxis by cis(Z)- and trans(E)-clopenthixol, and chlorpromazine. Acta Pathol Microbiol Immunol Scand C 1985 0.75
160 Immunological and clinical aspects of kidney disease in endemic typhoid fever in Iran. Q J Med 1984 0.75
161 Intralesional autotherapy of cutaneous leishmaniasis with buffy coat cells: cytological findings. Acta Trop 2000 0.75
162 Purification and enzymatic activity of an NADH-fumarate reductase and other mitochondrial activities of Leishmania parasites. APMIS 2001 0.75
163 Fusidic acid and human phagocyte function. J Antimicrob Chemother 1988 0.75
164 Mechanism of action of antibiotics in chronic pulmonary pseudomonas infection. Adv Pharmacol 1994 0.75